THE RISKY TIMETABLE OF CORONAVIRUS VACCINE

                If a person develops symptoms of Coronavirus disease no matter the way get infected with, the doctor will determine whether to conduct tests for Coronavirus based on the symptoms, as well as having close contact with someone diagnosed with Coronavirus or traveled to or lived in any areas with ongoing community spread of Covid-19 in the past 14 days, the doctor may also consider testing if there is a higher risk of serious illness, to test for Coronavirus, a health care provider uses a long swab to take a nasal sample or a coughing up saliva sample. The sample is then sent to a lab for testing. There are laboratory tests that can identify the virus that causes Coronavirus in respiratory specimens, state and local public health departments have received tests from the Centers for Disease Control and Prevention CDC while medical providers are getting tests developed by commercial manufacturers.
Scientists across the world are racing to develop a Coronavirus vaccine, but once a vaccine is developed and approved, who has access to it could depend on the results of the 2020 census: The count is mandated by the constitution and conducted be the US Census Bureau, a nonpartisan government agency, the 2020 census counts the population in the United States and five US territories "Puerto Rico, American Samoa, The Commonwealth of the Northern Mariana Islands, Guam and the US Virgin Islands" each home will receive an invitation to respond to a short questionnaire online, by phone or by mail, between March 12 and 20, that's because US government agencies look at census data to figure out how to allocate resources, if the population of a community is under counted, it might not get the volume of Coronavirus vaccine it needs, said Rob Santos, chief methodological at the Urban Institute, if in a year or two years from now, we finally have vaccines, the first thing that the public health folks are going to do is they are going to look at the census counts by neighborhood and say, where do we push out vaccines? Santos said. If people don't participate, then they are at risk of getting less vaccines than they should have gotten, it's a scenario that Census Bureau spokesman Michael Cook has hinted at in the past. As a federal agency, we are obligated to conduct the Census per the Census law, so we are  trying to ensure that the Census is continuing because we have to conduct the Census but that when and where possible, we are making adaptations and modifications to all of our operations to ensure the safety of the public and our staff because we are practicing social distancing and ensuring we can lessen the spread of Coronavirus.
An accurate 2020 Census does bode well for times when emergency preparedness or first res-ponders need that information, looking at the health industry and everything that's happening with Coronavirus, the official statistics of the United States definitely will be used and come into play, Cook said. The Census has been underway since the beginning of March and can be filled out online, experts fear that because of the Coronavirus, getting an accurate count of the US population by the December 31 deadline will be harder, with more than 75% of Americans on some form of lock down. Lizette Escobedo, director of national Census program NALEO Educational Fund said, Historically, Minority groups such as African Americans, Latinos, people on tribal lands, the homeless and rural populations have been the hardest to count, they have very limited access to information around the Census and around most civic engagement issues, there are language barriers and with that comes barriers to access, I think another piece is there is a huge distrust for the government. That's why the Census Bureau usually sends field workers to collect data but during the pandemic, it has suspended all field operations until after April 15 as it tries to figure out how to protect the army of door knockers from Coronavirus, instead, the agency is urging folks to fill out the form online or over the phone but despite the challenges presented by the Coronavirus, Census officials say there is not much flexibility to extend the deadline, since the US constitution mandates a Census every 10 years. 
Currently there is no antiviral medication is recommended to treat Coronavirus, treatment is directed at relieving symptoms and may include pain relievers ibuprofen or acetaminophen, cough syrup or medication, rest and fluid intake. 18 months might sound like a long time but in vaccine years, it's a blink, that's the long end of the Trump administration's time window for developing a Coronavirus vaccine and some leaders in the field say this is too fast and could come at the expense of safety, the estimated time made headlines last month, when Trump remarked at a televised Cabinet Room meeting with pharmaceutical executives that a vaccine could be ready in three to four months, in front of TV cameras, Dr Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases NIAID, poured cold water on Trump's estimate, saying it would be more like a year to year and a half, ever since, that estimate of 12 to 18 months has become gospel, its appearance in media stories ubiquitous but medical experts and scientists with firsthand experience developing vaccines are skeptical, Tony Fauci is saying a year to 18 months, i think it's optimistic, said Dr Peter Hotez, a leading expert on infectious disease and vaccine development at Baylor College of Medicine, maybe if all the stars align, but probably longer. Vaccines development typically measured in years not months, as the number of Coronavirus death cases escalating, the pressure on the scientific community to find a vaccine is immense, in just a few weeks, the virus has jammed the gears of a robust economy and destroyed millions of jobs, fear is off the charts and with that comes the pressure to find a fix. The first federally funded trial for Coronavirus kicked off at Kaiser Permanente Washington Health Research Institute in Seattle, it expanded to Emory University in Atlanta, 45 volunteers in the Seattle and Atlanta communities are participating in the first phase of the trial, experts say the problem is the oft-stated timetable is ambitious at best, vaccine trials typically start with testing in animals before launching into a three phase process according to the CDC:

1.  The First phase involves injecting the vaccine into a small group of people to assess safety and monitor their immune response.
2.  The second ramps up the number of people, often into the hundreds and often including more members of at-risk groups, for a randomized trial, if the results are promising the trial moves to phase three.
3.  Phase three test for efficacy and safety with thousands or tens of thousands of people.

Dr Emily Erbelding, an infectious disease expert at NIAID which is a part of the National Institute of Health said, The typical vaccine takes between 8 and 10 years to develop, while she is careful not to contradict her boss's timeline. 18 months would be about as fast as i think we can go. She acknowledged that the accelerated pace will involve not looking at all the data, because we are in a race here to beat back this epidemic and a vaccine is very important, people might be willing to take a chance on just going quickly into phase two, so the 18 months would rely upon speeding things up. Volunteers in each phase need to be monitored for safety, Dr Erbelding said, Usually you want to follow their immune response for at least a year. But that's not what will be happening in the current study in Seattle and Atlanta, where researchers will test animals and humans in parallel, as opposed to sequentially.